FI973089A - Human interleukin-1 receptor auxiliary protein - Google Patents
Human interleukin-1 receptor auxiliary protein Download PDFInfo
- Publication number
- FI973089A FI973089A FI973089A FI973089A FI973089A FI 973089 A FI973089 A FI 973089A FI 973089 A FI973089 A FI 973089A FI 973089 A FI973089 A FI 973089A FI 973089 A FI973089 A FI 973089A
- Authority
- FI
- Finland
- Prior art keywords
- human interleukin
- auxiliary protein
- receptor
- receptor auxiliary
- protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Emergency Medicine (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37626895A | 1995-01-23 | 1995-01-23 | |
| PCT/EP1996/000181 WO1996023067A1 (en) | 1995-01-23 | 1996-01-17 | Human interleukin-1 receptor accessory protein |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI973089A true FI973089A (en) | 1997-07-22 |
| FI973089A0 FI973089A0 (en) | 1997-07-22 |
Family
ID=23484321
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI973089A FI973089A0 (en) | 1995-01-23 | 1997-07-22 | Human interleukin-1 receptor auxiliary protein |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0808365A1 (en) |
| JP (1) | JPH10512453A (en) |
| AR (1) | AR003919A1 (en) |
| AU (1) | AU4537096A (en) |
| BR (1) | BR9606837A (en) |
| CA (1) | CA2210724A1 (en) |
| CO (1) | CO4480033A1 (en) |
| CZ (1) | CZ208197A3 (en) |
| EA (1) | EA199700265A1 (en) |
| FI (1) | FI973089A0 (en) |
| HU (1) | HUP9702458A2 (en) |
| IL (1) | IL116796A0 (en) |
| MX (1) | MX9705501A (en) |
| NO (1) | NO973404D0 (en) |
| PE (1) | PE64396A1 (en) |
| PL (1) | PL321538A1 (en) |
| TR (1) | TR199700652T1 (en) |
| WO (1) | WO1996023067A1 (en) |
| ZA (1) | ZA96333B (en) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998008969A1 (en) * | 1996-08-26 | 1998-03-05 | Human Genome Sciences, Inc. | Soluble interleukin-1 receptor accessory molecule |
| US6974682B1 (en) | 1996-08-26 | 2005-12-13 | Human Genome Sciences, Inc. | Soluble interleukin-1 receptor accessory molecule |
| ATE406176T1 (en) | 1996-12-06 | 2008-09-15 | Amgen Inc | IL-1 INHIBITOR IN COMBINATION THERAPY FOR THE TREATMENT OF IL-1-MEDIATED DISEASES |
| US6294170B1 (en) | 1997-08-08 | 2001-09-25 | Amgen Inc. | Composition and method for treating inflammatory diseases |
| CA2287876A1 (en) * | 1997-04-30 | 1998-11-05 | F. Hoffmann-La Roche Ag | Rat st38.2 chemokine |
| US6280955B1 (en) * | 1997-12-16 | 2001-08-28 | Tularik Inc. | Interleukin-1 receptor accessory proteins, nucleic acids and methods |
| IL136696A0 (en) | 1997-12-23 | 2001-06-14 | Immunex Corp | Sigirr dna and polypeptides |
| US6808902B1 (en) | 1999-11-12 | 2004-10-26 | Amgen Inc. | Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules |
| WO2002064630A2 (en) * | 2000-10-31 | 2002-08-22 | Immunex Corporation | Il-1 receptor accessory protein |
| GB2375604A (en) * | 2001-05-18 | 2002-11-20 | Warner Lambert Co | Methods for screening using interleukin soluble trimolecular complex |
| EP2087908B1 (en) | 2001-06-26 | 2018-05-30 | Amgen Inc. | Antibodies to opgl |
| KR100453877B1 (en) | 2001-07-26 | 2004-10-20 | 메덱스젠 주식회사 | METHOD OF MANUFACTURING Ig-FUSION PROTEINS BY CONCATAMERIZATION, TNFR/Fc FUSION PROTEINS MANUFACTURED BY THE METHOD, DNA CODING THE PROTEINS, VECTORS INCLUDING THE DNA, AND CELLS TRANSFORMED BY THE VECTOR |
| US20030049255A1 (en) * | 2001-08-07 | 2003-03-13 | Sims John E. | Interleukin-1 receptors in the treatment of diseases |
| CA2497884C (en) | 2002-09-06 | 2013-10-22 | Brian Varnum | Therapeutic human anti-il-1r1 monoclonal antibody |
| HUE040595T2 (en) | 2004-04-02 | 2019-03-28 | Swedish Orphan Biovitrum Ab Publ | Methods of reducing aggregation of il-1ra |
| JP5064212B2 (en) * | 2004-05-05 | 2012-10-31 | ヴァロリザーシヨン−ルシェルシュ，ソシエテ・アン・コマンディット | INTERLEUKIN-1 RECEPTOR ANTAGONIST, COMPOSITION AND METHOD OF TREATMENT |
| US8618054B2 (en) | 2004-05-05 | 2013-12-31 | Valorisation-Rechereche Société en Commandite | Interleukin-1 receptor antagonists, compositions, and methods of treatment |
| AU2006264567A1 (en) * | 2005-05-05 | 2007-01-11 | Valorisation Hsj, Societe En Commandite | Cytokine receptor modulators and uses thereof |
| PE20070684A1 (en) | 2005-11-14 | 2007-08-06 | Amgen Inc | RANKL-PTH / PTHrP ANTIBODY CHEMERICAL MOLECULES |
| JP2011515497A (en) * | 2008-03-26 | 2011-05-19 | セレラント セラピューティクス インコーポレイテッド | Immunoglobulins and / or Toll-like receptor proteins associated with myeloid hematological proliferative diseases and uses thereof |
| EP2196476A1 (en) | 2008-12-10 | 2010-06-16 | Novartis Ag | Antibody formulation |
| GB2472856B (en) | 2009-08-21 | 2012-07-11 | Cantargia Ab | IL1-RAP modulators and uses thereof |
| US11939634B2 (en) | 2010-05-18 | 2024-03-26 | Natera, Inc. | Methods for simultaneous amplification of target loci |
| RU2597831C2 (en) | 2011-01-19 | 2016-09-20 | Кантаргия Аб | Anti-il1rap antibodies and their use for treating human |
| JP6153874B2 (en) | 2011-02-09 | 2017-06-28 | ナテラ， インコーポレイテッド | Method for non-invasive prenatal ploidy calls |
| WO2012177595A1 (en) * | 2011-06-21 | 2012-12-27 | Oncofactor Corporation | Compositions and methods for the therapy and diagnosis of cancer |
| WO2013006490A2 (en) | 2011-07-01 | 2013-01-10 | Cellerant Therapeutics, Inc. | Antibodies that specifically bind to tim3 |
| GB201403875D0 (en) | 2014-03-05 | 2014-04-16 | Cantargia Ab | Novel antibodies and uses thereof |
| GB201413913D0 (en) | 2014-08-06 | 2014-09-17 | Cantargia Ab | Novel antibodies and uses thereof |
| WO2016183106A1 (en) | 2015-05-11 | 2016-11-17 | Natera, Inc. | Methods and compositions for determining ploidy |
| WO2016207304A2 (en) | 2015-06-26 | 2016-12-29 | Mab Discovery Gmbh | Monoclonal anti-il-1racp antibodies |
| EP3241845A1 (en) | 2016-05-06 | 2017-11-08 | MAB Discovery GmbH | Humanized anti-il-1r3 antibodies |
| US10041044B2 (en) | 2016-07-29 | 2018-08-07 | Trustees Of Boston University | Age-associated clonal hematopoiesis accelerates cardio-metabolic disease development |
| EP3401332A1 (en) | 2017-05-08 | 2018-11-14 | MAB Discovery GmbH | Anti-il-1r3 antibodies for use in inflammatory conditions |
| EP3642353A4 (en) | 2017-06-20 | 2021-02-24 | The Medical College of Wisconsin, Inc. | Assessing transplant complication risk with total cell-free dna |
| US12024738B2 (en) | 2018-04-14 | 2024-07-02 | Natera, Inc. | Methods for cancer detection and monitoring |
| TW202021618A (en) | 2018-08-17 | 2020-06-16 | 美商２３與我有限公司 | Anti-il1rap antibodies and methods of use thereof |
| US11931674B2 (en) | 2019-04-04 | 2024-03-19 | Natera, Inc. | Materials and methods for processing blood samples |
| WO2021236962A1 (en) | 2020-05-20 | 2021-11-25 | The Medical College Of Wisconsin, Inc. | Compositions and methods for inhibiting cytokine-release syndrome |
| CN114835799A (en) * | 2021-05-28 | 2022-08-02 | 百奥赛图江苏基因生物技术有限公司 | Construction method and application of IL1RAP gene humanized non-human animal |
-
1996
- 1996-01-15 PE PE1996000031A patent/PE64396A1/en not_active Application Discontinuation
- 1996-01-16 ZA ZA96333A patent/ZA96333B/en unknown
- 1996-01-17 EP EP96901291A patent/EP0808365A1/en not_active Withdrawn
- 1996-01-17 MX MX9705501A patent/MX9705501A/en unknown
- 1996-01-17 AU AU45370/96A patent/AU4537096A/en not_active Abandoned
- 1996-01-17 IL IL11679696A patent/IL116796A0/en unknown
- 1996-01-17 CZ CZ972081A patent/CZ208197A3/en unknown
- 1996-01-17 PL PL96321538A patent/PL321538A1/en unknown
- 1996-01-17 JP JP8522598A patent/JPH10512453A/en active Pending
- 1996-01-17 CA CA002210724A patent/CA2210724A1/en not_active Abandoned
- 1996-01-17 BR BR9606837A patent/BR9606837A/en unknown
- 1996-01-17 TR TR97/00652T patent/TR199700652T1/en unknown
- 1996-01-17 EA EA199700265A patent/EA199700265A1/en unknown
- 1996-01-17 WO PCT/EP1996/000181 patent/WO1996023067A1/en not_active Application Discontinuation
- 1996-01-17 HU HU9702458A patent/HUP9702458A2/en unknown
- 1996-01-19 AR ARP960101095A patent/AR003919A1/en unknown
- 1996-01-22 CO CO96002329A patent/CO4480033A1/en unknown
-
1997
- 1997-07-22 FI FI973089A patent/FI973089A0/en unknown
- 1997-07-23 NO NO973404A patent/NO973404D0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA96333B (en) | 1996-07-23 |
| AR003919A1 (en) | 1998-09-30 |
| PE64396A1 (en) | 1997-01-28 |
| IL116796A0 (en) | 1996-05-14 |
| EP0808365A1 (en) | 1997-11-26 |
| NO973404L (en) | 1997-07-23 |
| CA2210724A1 (en) | 1996-08-01 |
| HUP9702458A2 (en) | 1998-04-28 |
| CO4480033A1 (en) | 1997-07-09 |
| FI973089A0 (en) | 1997-07-22 |
| CZ208197A3 (en) | 1997-11-12 |
| NO973404D0 (en) | 1997-07-23 |
| AU4537096A (en) | 1996-08-14 |
| BR9606837A (en) | 1998-05-26 |
| TR199700652T1 (en) | 1998-02-21 |
| PL321538A1 (en) | 1997-12-08 |
| JPH10512453A (en) | 1998-12-02 |
| EA199700265A1 (en) | 1998-04-30 |
| WO1996023067A1 (en) | 1996-08-01 |
| MX9705501A (en) | 1997-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI973089A (en) | Human interleukin-1 receptor auxiliary protein | |
| DE69634703D1 (en) | Multiple adjustable seat unit | |
| DE69634739D1 (en) | HEIGHT-ADJUSTABLE ARMRESTS | |
| DE69612316D1 (en) | Articulated armrest | |
| DE69528180D1 (en) | MODIFIED Whey Protein | |
| BR9610239A (en) | Xcd32-allergen-fusion proteins | |
| DE69517674D1 (en) | Adjustable seating arrangement | |
| FI955400A0 (en) | Chair | |
| DE69615850D1 (en) | G PROTEIN COUPLED RECEPTOR HNFD578 | |
| KR970007965U (en) | chair | |
| KR970019006U (en) | chair | |
| KR960030269U (en) | Chair | |
| KR970007961U (en) | Chair | |
| FI103946B1 (en) | Seat | |
| KR970008134U (en) | Wheelchair cushion | |
| BR7502674U (en) | Relax chair | |
| SE9503962D0 (en) | Adjustable backrest | |
| IT240237Y1 (en) | REMOVABLE CHAIR | |
| KR970015433U (en) | Wedge Human Clamp | |
| KR970026773U (en) | chair | |
| KR970007957U (en) | chair | |
| KR960026611U (en) | Backrest | |
| KR970031423U (en) | Relax seat | |
| KR960028635U (en) | Vibrator for Seat | |
| KR960036852U (en) | Removable armrest |